117 related articles for article (PubMed ID: 5333777)
1. Phenothiazines in prevention of psychiatric hospitalization. IV. Delay or prevention of hospitalization--a reevaluation.
Engelhardt DM; Rosen B; Freedman N; Margolis R
Arch Gen Psychiatry; 1967 Jan; 16(1):98-101. PubMed ID: 5333777
[No Abstract] [Full Text] [Related]
2. The hospitalization proneness scale as a predictor of response to phenothiazine treatment. II. Delay of psychiatric hospitalization.
Rosen B; Engelhart DM; Freedman N; Margolis R; Klein DF
J Nerv Ment Dis; 1971 Jun; 152(6):405-11. PubMed ID: 4935067
[No Abstract] [Full Text] [Related]
3. The hospitalization proneness scale as a predictor of response to phenothiazine treatment.
Rosen B; Engelhardt DM; Freedman N; Margolis R
J Nerv Ment Dis; 1968 Jun; 146(6):476-80. PubMed ID: 5677025
[No Abstract] [Full Text] [Related]
4. PHENOTHIAZINES IN PREVENTION OF PSYCHIATRIC HOSPITALIZATION. 3. DELAY OR PREVENTION OF HOSPITALIZATION.
ENGELHARDT DM; FREEDMAN N; ROSEN B; MANN D; MARGOLIS R
Arch Gen Psychiatry; 1964 Aug; 11():162-9. PubMed ID: 14237612
[No Abstract] [Full Text] [Related]
5. PHENOTHIAZINES IN PREVENTION OF PSYCHIATRIC HOSPITALIZATION. II. DURATION OF TREATMENT EXPOSURE.
ENGELHARDT DM; ROSEN B; FREEDMAN N; MANN D; MARGOLIS R
JAMA; 1963 Dec; 186():981-3. PubMed ID: 14066719
[No Abstract] [Full Text] [Related]
6. Prediction of psychiatric hospitalization. II. The Hospitalization Proneness Scale: a cross-validation.
Rosen B; Engelhardt DM; Freedman N; Margolis R; Rudorfer L; Paley HM
J Abnorm Psychol; 1972 Dec; 80(3):271-4. PubMed ID: 4639912
[No Abstract] [Full Text] [Related]
7. Physician bias and the double-blind.
Engelhardt DM; Margolis RA; Rudorfer L; Paley HM
Arch Gen Psychiatry; 1969 Mar; 20(3):315-20. PubMed ID: 4884940
[No Abstract] [Full Text] [Related]
8. On the modification of paranoid symptomatology. II. Stylistic considerations and the effectiveness of phenothiazines.
Freedman N; Cutler R; Engelhardt DM; Margolis R
J Nerv Ment Dis; 1970 Jan; 150(1):68-76. PubMed ID: 4906641
[No Abstract] [Full Text] [Related]
9. Recent developments in the drug treatment of schizophrenia.
Davis JM
Am J Psychiatry; 1976 Feb; 133(2):208-14. PubMed ID: 766652
[TBL] [Abstract][Full Text] [Related]
10. Prediction of response to phenothiazines in schizophrenia. A crossvalidation study.
Goldberg SC; Frosch WA; Drossman AK; Schooler NR; Johnson GF
Arch Gen Psychiatry; 1972 Apr; 26(4):367-73. PubMed ID: 4552130
[No Abstract] [Full Text] [Related]
11. A study of the withdrawal of chlorpromazine or trifluoperazine in chronic schizophrenia.
Morton MR
Am J Psychiatry; 1968 May; 124(11):1585-8. PubMed ID: 4869439
[No Abstract] [Full Text] [Related]
12. A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics.
Keskiner A; Itil TM; Todt N
Psychosomatics; 1970; 11(2):120-6. PubMed ID: 4394278
[No Abstract] [Full Text] [Related]
13. THE INFLUENCE OF PREVIOUS HOSPITALIZATION ON THE CLINICAL COURSE OF PSYCHOPHARMACOLOGICALLY TREATED SCHIZOPHRENIC OUTPATIENTS.
ENGELHARDT D; FREEDMAN N; MANN D
Compr Psychiatry; 1963 Oct; 4():337-42. PubMed ID: 14055432
[No Abstract] [Full Text] [Related]
14. EFFECTS OF PSYCHOTROPIC DRUGS ON LONG-TERM ADJUSTMENT. A REVIEW.
GITTELMAN RK; KLEIN DF; POLLACK M
Psychopharmacologia; 1964 Apr; 5():317-38. PubMed ID: 14151546
[No Abstract] [Full Text] [Related]
15. Family interaction patterns, drug treatment, and change in social aggression.
Cohen M; Freedman N; Engelhardt DM; Margolis RA
Arch Gen Psychiatry; 1968 Jul; 19(1):50-6. PubMed ID: 5661009
[No Abstract] [Full Text] [Related]
16. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
Tetreault L
Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
[No Abstract] [Full Text] [Related]
17. [Clinical evaluation of the action of dixyrazine on behavioral disorders in children treated in a medico-pedagogic institution].
d' Hollander L; Fontaine PJ; Stassart-Deryck T
Acta Neurol Psychiatr Belg; 1967; 67():Suppl:5-35. PubMed ID: 4964203
[No Abstract] [Full Text] [Related]
18. The immediate effects of chlorpromazine in newly admitted schizophrenic patients.
Hamill WT; Fontana AF
Am J Psychiatry; 1975 Oct; 132(10):1023-6. PubMed ID: 1101707
[TBL] [Abstract][Full Text] [Related]
19. Quantitative comparison of clinical effectiveness of chlorpromazine and promazine.
GILMORE TH; SHATIN L
J Ment Sci; 1959 Apr; 105(439):508-10. PubMed ID: 13665315
[No Abstract] [Full Text] [Related]
20. COMMUNICATION OF BODY COMPLAINTS AND PARANOID SYMPTOM CHANGE UNDER CONDITIONS OF PHENOTHIAZINE TREATMENT.
FREEDMAN N; ENGELHARDT D; MANN D; MARGOLIS R; LONDON S
J Pers Soc Psychol; 1965 Apr; 1():310-8. PubMed ID: 14328737
[No Abstract] [Full Text] [Related]
[Next] [New Search]
